FDA OKs gene-targeting skin cancer drug

* AP Wire Published:

WASHINGTON (AP) -- The Food and Drug Administration has approved a first-of-a-kind drug to treat the deadliest form of skin cancer by targeting a particular genetic mutation found in about half of patients. The pill